BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 30195145)

  • 1. Mean platelet volume and long-term cardiovascular outcomes in patients with stable coronary artery disease.
    Wada H; Dohi T; Miyauchi K; Shitara J; Endo H; Doi S; Tsuboi S; Ogita M; Iwata H; Kasai T; Okazaki S; Isoda K; Suwa S; Daida H
    Atherosclerosis; 2018 Oct; 277():108-112. PubMed ID: 30195145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of Mean Platelet Volume and Neutrophil to Lymphocyte Ratio Predicts Long-Term Major Adverse Cardiovascular Events After Percutaneous Coronary Intervention.
    Choi DH; Kobayashi Y; Nishi T; Kim HK; Ki YJ; Kim SS; Park KH; Song H; Fearon WF
    Angiology; 2019 Apr; 70(4):345-351. PubMed ID: 29631419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mean Platelet Volume and Major Adverse Cardiac Events following Percutaneous Coronary Intervention.
    Nozari Y; Parsa M; Jalali A; Ariannejad H; Shafiee A
    Arch Iran Med; 2019 Apr; 22(4):198-203. PubMed ID: 31126178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of neutrophil-to-lymphocyte ratio and mean platelet volume in the prediction of adverse events after primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction.
    Machado GP; Araujo GN; Carpes CK; Lech M; Mariani S; Valle FH; Bergoli LCC; Gonçalves SC; Wainstein RV; Wainstein MV
    Atherosclerosis; 2018 Jul; 274():212-217. PubMed ID: 29803159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of platelet turnover on long-term adverse cardiovascular outcomes in patients undergoing percutaneous coronary intervention.
    Tscharre M; Farhan S; Bruno V; Rohla M; Egger F; Weiss TW; Hübl W; Willheim M; Wojta J; Geppert A; Huber K; Freynhofer MK
    Eur J Clin Invest; 2019 Sep; 49(9):e13157. PubMed ID: 31318979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of dual antiplatelet therapy on mean platelet volume in patients with coronary artery disease undergoing percutaneous coronary intervention.
    Higaki T; Kurisu S; Watanabe N; Ikenaga H; Shimonaga T; Iwasaki T; Mitsuba N; Ishibashi K; Dohi Y; Fukuda Y; Kihara Y
    Heart Vessels; 2016 Mar; 31(3):269-74. PubMed ID: 25381477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre-procedural neutrophil-to-lymphocyte ratio and long-term cardiac outcomes after percutaneous coronary intervention for stable coronary artery disease.
    Wada H; Dohi T; Miyauchi K; Shitara J; Endo H; Doi S; Konishi H; Naito R; Tsuboi S; Ogita M; Kasai T; Hassan A; Okazaki S; Isoda K; Suwa S; Daida H
    Atherosclerosis; 2017 Oct; 265():35-40. PubMed ID: 28843126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of Mean Platelet Volume to Predict Significant Coronary Artery Disease in Patients With Non-ST-Elevation Acute Coronary Syndromes.
    Taskesen T; Sekhon H; Wroblewski I; Goldfarb M; Ahmad MB; Nguyen QT; Fughhi IA; Gidron A; Dadkhah S
    Am J Cardiol; 2017 Jan; 119(2):192-196. PubMed ID: 27814786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic implications of mean platelet volume on short- and long-term outcomes among patients with non-ST-segment elevation myocardial infarction treated with percutaneous coronary intervention: A single-center large observational study.
    Wasilewski J; Desperak P; Hawranek M; Ciślak A; Osadnik T; Pyka Ł; Gawlita M; Bujak K; Niedziela J; Krawczyk M; Gąsior M
    Platelets; 2016 Jul; 27(5):452-8. PubMed ID: 26939525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of mean platelet volume on postintervention coronary blood flow in patients with chronic stable angina pectoris.
    Duygu H; Turkoglu C; Kirilmaz B; Turk U
    J Invasive Cardiol; 2008 Mar; 20(3):120-4. PubMed ID: 18316827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of the Coronary Artery Bypass Graft SYNTAX Score (Synergy Between Percutaneous Coronary Intervention With Taxus) as a Prognostic Marker for Patients With Previous Coronary Artery Bypass Graft Surgery After Percutaneous Coronary Intervention.
    Miyagi T; Asaumi Y; Nishimura K; Nakashima T; Sakamoto H; Nakao K; Kanaya T; Nagai T; Shimabukuro Y; Miyamoto Y; Fujita T; Kusano K; Anzai T; Kobayashi J; Noguchi T; Ogawa H; Yasuda S
    Circ Cardiovasc Interv; 2016 Sep; 9(9):. PubMed ID: 27578838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between White Blood Count to Mean Platelet Volume Ratio and Clinical Outcomes and Severity of Coronary Artery Disease in Patients Undergoing Primary Percutaneous Coronary Intervention.
    Emre AR; Yasar KA; Atakan Y; Orhan C; Murathan K
    Cardiovasc Ther; 2020; 2020():9625181. PubMed ID: 32934665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two-year prognostic value of mean platelet volume in patients with diabetes and stable coronary artery disease undergoing elective percutaneous coronary intervention.
    Jiang P; Song Y; Xu JJ; Wang HH; Jiang L; Zhao W; Zhao XY; Chen J; Gao Z; Qiao SB; Yang YJ; Gao RL; Xu B; Yuan JQ
    Cardiol J; 2019; 26(2):138-146. PubMed ID: 30009376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of platelet indices after acute myocardial infarction treated with primary percutaneous coronary intervention.
    Rechciński T; Jasińska A; Foryś J; Krzemińska-Pakuła M; Wierzbowska-Drabik K; Plewka M; Peruga JZ; Kasprzak JD
    Cardiol J; 2013; 20(5):491-8. PubMed ID: 24469872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive Value of Mean Platelet Volume/Platelet Count for Prognosis in Acute Myocardial Infarction.
    Tian C; Song J; He D; Wu J; Sun Z; Sun Z
    Int Heart J; 2018 Mar; 59(2):286-292. PubMed ID: 29563382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta-analysis.
    Chu SG; Becker RC; Berger PB; Bhatt DL; Eikelboom JW; Konkle B; Mohler ER; Reilly MP; Berger JS
    J Thromb Haemost; 2010 Jan; 8(1):148-56. PubMed ID: 19691485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The burden of major adverse cardiac events in patients with coronary artery disease.
    Tsai IT; Wang CP; Lu YC; Hung WC; Wu CC; Lu LF; Chung FM; Hsu CC; Lee YJ; Yu TH
    BMC Cardiovasc Disord; 2017 Jan; 17(1):1. PubMed ID: 28052754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical impact of high-sensitivity C-reactive protein during follow-up on long-term adverse clinical outcomes in patients with coronary artery disease treated with percutaneous coronary intervention.
    Shitara J; Ogita M; Wada H; Tsuboi S; Endo H; Doi S; Konishi H; Naito R; Dohi T; Kasai T; Okazaki S; Isoda K; Suwa S; Miyauchi K; Daida H
    J Cardiol; 2019 Jan; 73(1):45-50. PubMed ID: 30001869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of mean platelet volume with angiographic thrombus burden and short-term mortality in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Lai HM; Xu R; Yang YN; Ma YT; Li XM; Zhao Q; Chen QJ; Zhai H; Liu F; Chen BD
    Catheter Cardiovasc Interv; 2015 Mar; 85 Suppl 1():724-33. PubMed ID: 25630273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term clinical impact of serum albumin in coronary artery disease patients with preserved renal function.
    Wada H; Dohi T; Miyauchi K; Shitara J; Endo H; Doi S; Konishi H; Naito R; Tsuboi S; Ogita M; Kasai T; Hassan A; Okazaki S; Isoda K; Suwa S; Daida H
    Nutr Metab Cardiovasc Dis; 2018 Mar; 28(3):285-290. PubMed ID: 29289574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.